Search arXivSearch

arXiv subjects

Tim Downing

Publications and source records attributed to Tim Downing.

3 recordsLinked to original sources

Approaches to studying virus pangenome variation graphs

Pangenome variation graphs (PVGs) allow for the representation of genetic diversity in a more nuanced way than traditional reference-based approaches. Here we focus on how PVGs are a powerful tool for studying genetic variation in viruses, offering insights into the complexities of viral quasispecies, mutation rates, and population dynamics. PVGs originated in human genomics and hold great promise for viral genomics. Previous work has been constrained by small sample sizes and gene-centric methods, PVGs enable a more comprehensive approach to studying viral diversity. Large viral genome collections should be used to make PVGs, which offer significant advantages: we outline accessible tools to achieve this. This spans PVG construction, PVG file formats, PVG manipulation and analysis, PVG visualisation, measuring PVG openness, and mapping reads to PVGs. Additionally, the development of PVG-specific formats for mutation representation and personalised PVGs that reflect specific research questions will further enhance PVG applications. Challenges remain, particularly in managing nested variants, optimising error detection, optimising k-mer/minimizer-based approaches for AT-rich genomes, incorporating long read sequencing data, and scalable visualisation approaches. Nevertheless, PVGs offer a new opportunities for viral population genomics, and a testing ground for tool development prior to application to larger eukaryotic genomes. These advances will enable more accurate and comprehensive detection of viral mutations, contributing to a deeper understanding of viral evolution and genotype-phenotype associations.

q-bio.GN

A primer on correlation-based dimension reduction methods for multi-omics analysis

The continuing advances of omic technologies mean that it is now more tangible to measure the numerous features collectively reflecting the molecular properties of a sample. When multiple omic methods are used, statistical and computational approaches can exploit these large, connected profiles. Multi-omics is the integration of different omic data sources from the same biological sample. In this review, we focus on correlation-based dimension reduction approaches for single omic datasets, followed by methods for pairs of omics datasets, before detailing further techniques for three or more omic datasets. We also briefly detail network methods when three or more omic datasets are available and which complement correlation-oriented tools. To aid readers new to this area, these are all linked to relevant R packages that can implement these procedures. Finally, we discuss scenarios of experimental design and present road maps that simplify the selection of appropriate analysis methods. This review will guide researchers navigate the emerging methods for multi-omics and help them integrate diverse omic datasets appropriately and embrace the opportunity of population multi-omics.

q-bio.GN

Tackling drug resistant infection outbreaks of global pandemic Escherichia coli ST131 using evolutionary and epidemiological genomics

High-throughput molecular screening is required to investigate the origin and diffusion of antimicrobial resistance in pathogen outbreaks. The most frequent cause of human infection is Escherichia coli, which is dominated by sequence type 131 (ST131), a set of rapidly radiating pandemic clones. The highly infectious clades of ST131 originated firstly by a mutation enhancing virulence and adhesion. Secondly, single-nucleotide polymorphisms occurred enabling fluoroquinolone-resistance, which is near-fixed in all ST131. Thirdly, broader resistance through beta-lactamases has been gained and lost frequently, symptomatic of conflicting environmental selective effects. This flexible approach to gene exchange is worrying and supports the proposition that ST131 will develop an even wider range of plasmid and chromosomal elements promoting antimicrobial resistance. To stymie ST131, deep genome sequencing is required to understand the origin, evolution and spread of antimicrobial resistance genes. Phylogenetic methods that decipher past events can predict future patterns of virulence and transmission based on genetic signatures of adaptation and gene exchange. Both the effect of partial antimicrobial exposure and cell dormancy caused by variation in gene expression may accelerate the development of resistance. High-throughput sequencing can decode measurable evolution of cell populations within patients associated with systems-wide changes in gene expression during treatments. A multi-faceted approach can enhance assessment of antimicrobial resistance in E. coli ST131 by examining transmission dynamics between hosts to achieve a goal of pre-empting resistance before it emerges by optimising antimicrobial treatment protocols.

q-bio.PE